Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
1058 participants
INTERVENTIONAL
2020-01-06
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Financial Incentives for Smoking Treatment
NCT02506829
Pilot Randomized Control Trial of Financial Incentives for Smoking Cessation
NCT01303081
Financial Incentives for Smoking Cessation Treatment Engagement
NCT04601870
Small Financial Incentives to Promote Smoking Cessation
NCT02737566
Financial Incentives for Smoking Cessation
NCT00128375
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Goal-Directed Incentives
Smoking cessation counseling (Quitline)
Quitline offers community-based counseling session with a cessation counselor.
Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy)
Participants will be encouraged to speak to their doctors about using highly effective pharmacotherapies for smoking cessation.
Financial incentives for use of evidence-based smoking cessation therapies
Participants will receive financial incentives for the use of evidence-based smoking cessation therapies including Quitline counseling, community-based smoking cessation programs and pharmacotherapies
Outcome-Based Incentives
Smoking cessation counseling (Quitline)
Quitline offers community-based counseling session with a cessation counselor.
Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy)
Participants will be encouraged to speak to their doctors about using highly effective pharmacotherapies for smoking cessation.
Financial incentives for smoking cessation
Participants will receive financial incentives for bioconfirmed smoking cessation.
Enhanced Usual Care
Smoking cessation counseling (Quitline)
Quitline offers community-based counseling session with a cessation counselor.
Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy)
Participants will be encouraged to speak to their doctors about using highly effective pharmacotherapies for smoking cessation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Smoking cessation counseling (Quitline)
Quitline offers community-based counseling session with a cessation counselor.
Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy)
Participants will be encouraged to speak to their doctors about using highly effective pharmacotherapies for smoking cessation.
Financial incentives for smoking cessation
Participants will receive financial incentives for bioconfirmed smoking cessation.
Financial incentives for use of evidence-based smoking cessation therapies
Participants will receive financial incentives for the use of evidence-based smoking cessation therapies including Quitline counseling, community-based smoking cessation programs and pharmacotherapies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. smoked tobacco during the prior 30 days,
3. have an active U.S. phone number and address,
4. can provide consent in English or Spanish and
5. are in at least the contemplative stage of change for quitting smoking, as assessed by a single measure, readiness to quit
Exclusion Criteria
2. are pregnant or breastfeeding,
3. are discharged to an institution (e.g., nursing home, long-term care facility),
4. are unable to provide informed consent, or do not have cognitive ability to enroll or participate in the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Olive View-UCLA Education & Research Institute
OTHER
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Soma Wali
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joseph Ladapo, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Scott Sherman, MD
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
David Geffen School of Medicine
Los Angeles, California, United States
NYU Langone Health
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wali S, Gaitonde A, Sherman S, Min N, Pesantes A, Bidgoli A, Shirley A, Tseng CH, Ladapo J. Goal-directed versus outcome-based financial incentives for smoking cessation among low-income, hospitalised patients: rationale and design of the Financial Incentives for Smoking Treatment II (FIESTA II) randomised controlled trial. BMJ Open. 2023 Sep 29;13(9):e074354. doi: 10.1136/bmjopen-2023-074354.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.